NCT00075881 arm group c2a9f155c91ecc514c91976fd9685f8f [clinicaltrials_resource:NCT00075881/arm-group/c2a9f155c91ecc514c91976fd9685f8f]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00075881 arm group c2a9f155c91ecc514c91976fd9685f8f [clinicaltrials_resource:NCT00075881/arm-group/c2a9f155c91ecc514c91976fd9685f8f]
Bio2RDF identifier
NCT00075881/arm-group/c2a9f155c91ecc514c91976fd9685f8f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... a9f155c91ecc514c91976fd9685f8f
description [clinicaltrials_vocabulary:description]
INDUCTION TREATMENT: Patients ...... sion or unacceptable toxicity.
identifier
clinicaltrials_resource:NCT00075881/arm-group/c2a9f155c91ecc514c91976fd9685f8f
title
NCT00075881 arm group c2a9f155c91ecc514c91976fd9685f8f
@en
type
label
NCT00075881 arm group c2a9f155 ...... 9f155c91ecc514c91976fd9685f8f]
@en